Search Within

Amber Courtney King

Formats
  1. Meeting Abstract (14)
  2. Journal Article (11)
  3. Review (4)
  4. Research Letter (3)
Groups
  1. Adult Leukemia (27)
  2. Center for Hematologic Malignancies (27)
  3. Department of Medicine (27)
  4. Hematologic Malignancies, Division of (27)
  5. Hematology-Oncology Fellows (19)
  6. Weinberg Fellows (17)

More Groups

People
  1. Jae Park (11)
  2. Martin Tallman (11)
  3. Mark Geyer (10)
  4. Andriy Derkach (7)
  5. Eytan Stein (7)
  6. Troy Horvat (7)

More People

Years
  1. 2023 (1)
  2. 2022 (5)
  3. 2021 (3)
  4. 2020 (5)
  5. 2019 (10)
  6. 2018 (3)

More Years

Publications
  1. Blood (14)
  2. Leukemia Research (4)
  3. Annals of Pharmacotherapy (3)
  4. Leukemia and Lymphoma (3)
  5. Blood Advances (2)
  6. Journal of the Advanced Practitioner in Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Elsevier Ltd (4)
  3. Sage Publications (3)
  4. Taylor & Francis Group (3)
  5. Harborside Press (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (32)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cobimetinib-induced “dropped head syndrome” and subsequent disease management in an Erdheim-Chester patient
    Journal Article

    King, A. C.; Diamond, E. L.; Orozco, J. S.; Morse, H. R.; Ouyang, L. L.; Schöder, H.; Rampal, R. K.
    Clinical Case Reports (2019)

    Fulltext@MSK | Save
  • No loose ends: A review of the pharmacotherapy of hairy cell and hairy cell leukemia variant
    Review

    King, A. C.; Kabel, C. C.; Pappacena, J. J.; Stump, S. E.; Daley, R. J.
    Annals of Pharmacotherapy (2019)

    Fulltext@MSK | Save
  • CAR T-cell therapy and the pharmacology of managing cytokine release syndrome
    Review

    Park, J.; King, A. C.
    Journal of the Advanced Practitioner in Oncology (2019)

    Fulltext@MSK | Save
  • Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia
    Journal Article

    King, A. C.; Pappacena, J. J.; Tallman, M. S.; Park, J. H.; Geyer, M. B.
    Leukemia Research (2019)

    Fulltext@MSK | Save
  • Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia
    Meeting Abstract

    King, A. C.; Pappacena, J.; Tallman, M. S.; Park, J. H.; Geyer, M. B.
    Blood (2018)

    Fulltext@MSK | Save
  • Ruxolitinib in combination with dasatinib and dexamethasone is an active and well-tolerated chemotherapy-sparing oral induction regimen for adults with Philadelphia chromosome-positive ALL: Results of a phase I trial
    Meeting Abstract

    Geyer, M. B.; Burke, P. W.; King, A. C.; Mauro, M. J.; Tallman, M. S.; Levine, R. L.; Sherr, C. J.; Douer, D.; Park, J. H.
    Blood (2018)

    Fulltext@MSK | Save
  • The ABCs of immunotherapy for adult patients with B-cell acute lymphoblastic leukemia
    Journal Article

    Horvat, T. Z.; Seddon, A. N.; Ogunniyi, A.; King, A. C.; Buie, L. W.; Daley, R. J.
    Annals of Pharmacotherapy (2018)

    Fulltext@MSK | Save
  • Biomarkers for predicting toxicity and response in adult acute lymphoblastic leukemia (ALL) patients treated with blinatumomab
    Meeting Abstract

    King, A. C.; Daley, R. J.; Horvat, T. Z.; Hsu, M.; Park, J. H.
    Blood (2017)

    Fulltext@MSK | Save
  • Venetoclax combined with either a hypomethylating agent or low-dose cytarabine shows activity in relapsed and refractory myeloid malignancies
    Meeting Abstract

    Goldberg, A. D.; Horvat, T. Z.; Hsu, M.; Devlin, S. M.; Cuello, B. M.; Daley, R. J.; King, A. C.; Buie, L. W.; Glass, J. L.; Mauro, M. J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Venetoclax: A first-in-class oral BCL-2 inhibitor for the management of lymphoid malignancies
    Journal Article

    King, A. C.; Peterson, T. J.; Horvat, T. Z.; Rodriguez, M.; Tang, L. A.
    Annals of Pharmacotherapy (2017)

    Fulltext@MSK | Save